EFA at first ever online congress of allergic and respiratory patients in Spain
The Spanish Federation of Allergy and Airways Diseases Patients’ Associations (FENAER) inaugurated on the 8th of July in Madrid, Spain, the first Online...
Easing the economic burden of asthma
EFA Member, Asthma Society of Ireland, has published a new research confirming the enormity of the asthma burden and showing up-to-date figures on the...
SAVE THE DATE: World Atopic Eczema Day 14th September
On September 14th, EFA together with Global Skin we are marking the 2nd World Atopic Eczema Day with the theme BENEATH THE SURFACE to raise awareness and...
Allergy included for the first time in the International Classification of Diseases
The 72nd WHO World Health Assembly (WHA) held in Geneva late May adopted a revision of the International Classification of Diseases (ICD) that includes...
We spoke about adrenaline auto-injectors at the 2019 EAACI 2019 Congress
EFA participated in the European Academy of Allergy and Clinical Immunology (EAACI) Congress, celebrated in Lisbon from 1st to 5th June. The Congress is...
EFA response to EFSA consultation on the appropriate age for food diversification on babies
The European Food Safety Authority (EFSA) launched in April a public consultation on the appropriate age for the introduction of complementary feeding...
EFA response to EMA consultation on information on lactose
The European Medicines Agency (EMA) launched a public consultation that discussed the ‘Information for the package leaflet regarding lactose used as...
Push for an EU strategic framework to prevent non-communicable diseases
The European Chronic Disease Alliance (ECDA), the European Public Health Alliance (EPHA) and the Non-communicable Disease Alliance (NCD) have ...
New EU rules on tobacco distribution
The European Commission Directorate General on Internal Market, Industry, Entrepreneurship and SMEs (DG Grow) has introduced a draft act amending the Act...
Evaluation of the EU Environmental Action Programme: indoor and outdoor air quality failing
On May 15, the European Commission released its evaluation of the 7th Environmental Action Programme (EAP), which entered into force in 2014 and runs until...
EFA at ECHA Safer Chemicals conference
EFA participated in the European Chemicals Agency (ECHA) conference on Safer Chemicals, which took place in Helsinki on May 22nd. As official ECHA stakeholders,...
EFA at the EU Green Week 2019
The implementation of environmental legislation was also the main topic of this year’s EU Green Week, which took place in several cities across Europe...
Finnish EU Presidency Programme: Health insights
From 1st of July onwards, Finland will lead the European Council’s work for six months. The Scandinavian country plans to focus on the Economy of Wellbeing...
EFA atopic eczema scientific publications
Our study ITCHING FOR LIFE – Quality of Life and costs for people with severe atopic eczema in Europe continues to be to date the largest survey conducted...
Apply to participate in the IMI pool of patient experts
The Innovative Medicine Initiative (IMI) is a public-private partnership between the European Union and the European pharmaceutical industry. It is working...
FFAAIR celebrates its Annual Congress
In May 2019, EFA Member Fédération Française des Associations et Amicales de malades insuffisants ou handicapés Respiratoires (FFAIR) held its Annual...
Swedish Heart & Lung Association Congress
By the end of May, EFA member Riksförbundet HjärtLung held its annual congress.
Congratulations to President Inger Ros for her re-election!
aha! Swiss Allergy Center: Annual Report 2018
EFA Member, aha! Swiss Allergy Center has published its annual report 2018. The digital version can be found here.
FENAER launches its first Satellite Congress
EFA Spanish Member Federación Española de Asociaciones de pacientes alérgicos y con Enfermedades Respiratorias (FENAER) held its first online congress...
New Allergy & Asthma Foundation campaign focuses on hay fever in Denmark
In Denmark, up to one million people live with pollen allergy. Despite most of them are experiencing symptoms such as runny nose, sneezing and red eyes,...